LumiMeds review

Taking less costs you nothing less here, because nothing about the price responds to the dose — the plans differ only in how long you commit. Give LumiMeds credit for publishing a titration schedule in actual milligrams, from a quarter-milligram start upward, which most of this category will not do at all. It just never attaches a price to any rung of it. Two things cost you. Every figure on the product pages is the twelve-month floor, and paying that rate means handing over a year in a single charge; the recurring month-to-month rates are roughly double what the pages advertise. And the site's own footer Pricing link leads to a page that isn't there, so the one place you would go to check is missing. Credit where it is due on the arithmetic, though: every multi-month total divides exactly by its advertised per-month figure.

Vs median

$20/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

LumiMeds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

LumiMeds sells compounded semaglutide and compounded tirzepatide as weekly subcutaneous injections, plus NAD+, on monthly, three-, six- and twelve-month subscriptions. The plan set varies only by commitment length — there are no dose variants in it anywhere. Its product pages publish a per-month titration schedule in milligrams but attach no price to any rung, and quote only an "as low as" floor rather than the recurring rate. It describes itself as "a patient management platform" that "does not directly provide medical or pharmacy services", and no compounding pharmacy is named.

THE PLAN SET VARIES ONLY BY DURATION, NEVER BY DOSE — four semaglutide plans, four tirzepatide plans, no dose variants at all — so what a low dose costs cannot be established

• EVERY PUBLIC PRICE IS THE 12-MONTH PREPAY FLOOR. The product pages say only "as low as $89/mo" and "as low as $125/mo"; the month-to-month rates are $189 and $249, which is 112% and 99% higher
• "$89/mo" MEANS $1,068 CHARGED UP FRONT for a year, not a monthly bill
• The titration schedule is published in milligrams with no price against any rung, so the one place a dose appears is the one place a price does not
• lumimeds.com/pricing, the destination of the site's own footer Pricing link, does not resolve (checked 2026-08-10)
• Trust figures are asserted on the page — "Trusted by 50,000+ patients", "TrustScore 4.6, 925 reviews"
• No compounding pharmacy is named — only "Source 503A pharmacy" and "a state-licensed compounding pharmacy"
• States served are not published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

LumiMeds is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan